After winning approval in the United States back in September, Sanofi Genzyme’s multiple sclerosis drug, aubagio, has won approval for use in Australia. The Australian Therapeutic Goods ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

In the United States, Genzyme beat TKT and garnered exclusive US approval with the seven-year Orphan Drug exclusivity due to a superior clinical development programme. Experts believe that 4,000 ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

The FDA has cleared their once-weekly Factor VIII ... of the week,” according to Bill Sibold – head of the Sanofi Genzyme unit, which will be responsible for marketing the new drug – who ...

“Combining the three organizations at Genzyme is a strategic move in line ... and guideline changes often have a broad impact on drug developers, and organizations such as BIO provide advocacy ...

H1N1 Flu Wave Peaking in US? New cases of the H1N1 flu have declined, but deaths and hospitalizations are still rising. WebMD Health News, November 20, 2009 Med Schools and Ghostwriting As part of ...

Prior to BioMarin, Mr. Ajer served as Vice President, Global Transplant Operations at Genzyme Corporation and ... candidates for previously validated drug targets in commercially established ...

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterised by inflammatory lesions and neurodegeneration. Diagnosis often occurs in women of ...